Valganciclovir comment watch save
Breastfeeding

  • TRADE NAME: Valcyte (Roche)
  • INDICATIONS: Cytomegalovirus retinitis (CMV) in patients with AIDS, prevention of CMV disease in high-risk transplant patients
  • CLASS: Antiviral, Guanine nucleoside analog
  • HALF-LIFE: 4 hours (in severe renal impairment up to 68%)
  • See adverse reactions attributed to class:

    Antiviral

Valganciclovir is rapidly converted to ganciclovir in the body.

HEMATOLOGIC TOXICITY, IMPAIRMENT OF FERTILITY, FETAL TOXICITY, MUTAGENESIS AND CARCINOGENESIS

See full prescribing information for complete boxed warning.

Please login to view the rest of this drug profile.

Page last updated 07/31/2023

Symbol key

Incidence

<1% 1‑5% 5‑10% 10‑15% 15‑20% 20‑30% >30%

Seriousness

Hospitalization possible
Life threatening
Fatal

Warnings in other populations

BreastfeedingBreast feeding

GeriatricGeriatric

PediatricPediatric